Hongcheng Investment

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 18, 2023	IASO Biotherapeutics	$73.9M Series C	—	Efung Capital, Housen Care Brothers, Nanjing Jiangbei New Area State-owned Asset Management, Shanghai Guoxin Investment & Development, Shanghai Waigaoqiao Free Trade Zone Group

Total Raised

N/A

Valuation

N/A